Clinical trial
Ursodeoxycholic Acid in the Treatment of Duodenal Adenomas in Familial…
NCT00134758 · Assistance Publique - Hôpitaux de Paris, Other · Unknown status
Key facts
| NCT number | NCT00134758 |
|---|---|
| Title | Ursodeoxycholic Acid in the Treatment of Duodenal Adenomas in Familial Adenomatous Polyposis (FAP) Patients |
| Official title | Efficiency of Ursodesoxycholic Acid in the Treatment of Duodenal Adenomas in Familial Adenomatous Polyposis Patients. URSOPAF |
| Lead sponsor | Assistance Publique - Hôpitaux de Paris, Other |
| Collaborators | Axcan Pharma Industry |
| Status | Unknown status |
| Phase | Phase 2/Phase 3 |
| Study type | Interventional |
| Conditions | Adenomatous Polyposis Coli, Familial |
| Intervention type | Drug |
| Interventions | Ursodeoxycholic acid, Placebo |
| Enrollment | 90 |
| Start date | Oct 1, 2004 |
| Primary completion | Jun 1, 2009 |
| Completion | Oct 1, 2009 |
| First posted | Aug 25, 2005 |
| Last update posted | Jul 29, 2009 |
| Countries | France |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: